[1]
Fernando ME, Crowther RG, Cunningham M, Lazzarini PA, Sangla KS, Golledge J. Lower limb biomechanical characteristics of patients with neuropathic diabetic foot ulcers: the diabetes foot ulcer study protocol. BMC Endocr Disord 2015; 15: 59.
[2]
Howarth D. Putting feet first: Preventing avoidable amputations. J Diabetes Nurs 2017; 21(7): 235.
[3]
Donohue SJ. Lower limb amputation 3: the role of the nurse. Br J Nurs 1997; 6(20): 1171-91.
[4]
Amin N, Doupis J. Diabetic foot disease: From the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities. World J Diabetes 2016; 7(7): 153-64.
[5]
Pendsey SP. Understanding diabetic foot. Int J Diabetes Dev C 2010; 30(2): 75-9.
[6]
Tuttolomondo A, Maida C, Pinto A. Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes. World J Orthop 2015; 6(1): 62-76.
[7]
Armstrong D, Wrobel J, Robbins J. Guest editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J 2007; 4: 286-7.
[8]
Boulton A. The pathway to foot ulceration in diabetes. Med Clin North Am 2013; 97(5): 775-90.
[9]
Parisi MCR, Neto MA, Menezes FH, et al. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr 2016; 8: 25.
[10]
Wang A, Xu Z, Ji L. Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China. Zhonghua Yi Xue Za Zhi 2012; 92(4): 224-7.
[11]
Soewondo P, Ferrario A, Tahapary D. Challenges in Diabetes Management in Indonesia: A Literature Review. Global Health 2013; 9: 1-17.
[12]
Pemayun TGD, Naibaho RM, Novitasari D, Amin N, Minuljo TT. Risk factors for lower extremity amputation in patients with diabetic foot ulcers: A hospital based case-control study. Diabet Foot Ankle 2015; 6.
[13]
Peter-Riesch B. The diabetic foot: The never-ending challenge. Endocr Dev 2016; 31: 108-34.
[14]
Fejfarová V, Jirkovská A, Dragomirecká E, et al. Does the diabetic foot have a significant impact on selected psychological or social characteristics of patients with diabetes mellitus? J Diabetes Res 2014; 2014371938
[15]
Widatalla AH, Mahadi SEI, Shawer MA, Elsayem HA, Ahmed ME. Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation. Int J Diabetes Dev C 2009; 29(1): 1-5.
[16]
Delmas L. Best practice in the assessment and management of diabetic foot ulcers. Rehabil Nurs 2006; 31(6): 228-34.
[17]
Andrews KL, Houdek MT, Kiemele LJ. Wound management of chronic diabetic foot ulcers: From the basics to regenerative medicine. Prosthet Orthot Int 2015; 39(1): 29-39.
[18]
Holt P. Assessment and management of patients with diabetic foot ulcers. Nurs Stand 2013; 27(27): 49-55.
[19]
Turns M. Diabetic foot ulcer management: the podiatrist's perspective. Br J Community Nurs 2013; Suppl: S14: S16-9.
[20]
Krasner D, Sibbald R. Nursing management of chronic wounds: best practices across the continuum of care. Nurs Clin North Am 1999; 34(4): 933-53.
[21]
Marques A, Texeira A, Moreira T, Carvalho R, Fialho A, Chaves E. Nursing interventions for prevention of foot ulcers in patients with diabetes: an integrative review. Int Arch Med 2017; 10(163): 1-8.
[22]
Raile M, Marriner A. Nursing theorists and their work. 7th ed. New York: Mosby/Elsevier 2010.
[23]
Ganong L. Integrative reviews of nursing research. Res Nurs Health 1987; 10(1): 1-11.
[24]
Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs 2005; 52(5): 546-53.
[25]
Boisvert S, Proulx-Belhumeur A, Gonçalves N, Doré M, Francoeur J, Gallani MC. An integrative literature review on nursing interventions aimed at increasing self-care among heart failure patients. Rev Lat Am Nursing 2015; 23(4): 753-68.
[26]
Mantzoukas S. A review of evidence-based practice, nursing research and reflection: levelling the hierarchy. J Clin Nurs 2008; 17(2): 214-23.
[27]
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4(1): 1.
[28]
American Diabetes Association. Standards of medical care in diabetes-2016. Diabetes Care 2016; (Suppl. 1)S1-S112.
[29]
Roberts P, Newton V. Assessment and management of diabetic foot ulcers. Br J Community Nurs 2011; 19(10): 485-6. 8-90
[30]
Lazarus G, Cooper D, Knighton D, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994; 130: 489-93.
[31]
Turner V. Standardisation of wound care. Nurs Stand 1991; 5(19): 25-8.
[32]
Forsythe R, Hinchliffe R. Assessment of foot perfusion in patients with a diabetic foot ulcer. Diabetes Metab Res Rev 2016; 32(Suppl. 1): 232-8.
[33]
Young D, Flyinn K, Moss D, Schuerman S, Hartig K, Altenburger B. Reliability and Responsiveness of an 18 site, 10 g monofilament examination for assessment of protective foot sensation. J Geriatr Phys Ther 2011; 34: 95-8.
[34]
Richard J-L, Reilhes L, Buvry S, Goletto M, Faillie J-L. Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test. Int Wound J 2012; 11: 147-51.
[35]
Baraz S, Zarea K, Shahbazian HB, Latifi SM. Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening. J Diabetes Metab Syndr 2014; 13(1): 1-7.
[36]
Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther 2012; 3(1): 4.
[37]
Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin Temperature Monitoring Reduces the Risk for Diabetic Foot Ulceration in High-risk Patients. Am J Med 2007; 120(12): 1042-6.
[38]
Skafjeld A, Iversen MM, Holme I, Ribu L, Hvaal K, Kilhovd BK. A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes – a randomized controlled trial. BMC Endocr Disord 2015; 15(1): 1-7.
[39]
Álvaro-Afonso FJ, Lázaro-Martínez JL, Aragón-Sánchez J, García-Morales E, García-Álvarez Y, Molines-Barroso RJ. What is the clinical utility of the ankle-brachial index in patients with diabetic foot ulcers and radiographic arterial calcification? IJLEW 2015; 14(4): 372-6.
[40]
American Diabtes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26(1): 3333-41.
[41]
Brownrigg JRW, Hinchliffe RJ, Apelqvist J, et al. Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev 2016; 32: 128-35.
[42]
Rac-Albu M, Iluita L, Guberna S, Sinescud C. The role of ankle-brachial index for predicting peripheral arterial disease. Maedica (Buchar) 2014; 9(3): 295-302.
[43]
Rayman G, Vas PR, Baker N, et al. The Ipswich Touch Test: A simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 2011; 34(7): 1517-8.
[44]
Sharma S, Kerry C, Atkins H, Rayman G. The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Diabet Med 2014; 31(9): 1100-3.
[45]
Madanat A, Sheshah E, Badawy E, Abbas A, Al-Bakheet A. Utilizing the Ipswich Touch Test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience. Prim Care Diabetes 2015; 9(4): 304-6.
[46]
Woodbury MG, Sibbald RG, Ostrow B, Persaud R, Lowe JM. Tool for rapid & easy identification of high risk diabetic foot: Validation & clinical pilot of the simplified 60 second diabetic foot screening tool. PLoS One 2015; 10(6) e0125578
[47]
Greatrex-White S, Moxey H. Wound assessment tools and nurses’ needs: an evaluation study. Int Wound J 2013; 12(3): 293-301.
[48]
Bowering CK. Diabetic foot ulcers. Pathophysiology, assessment, and therapy. CFP 2001; 47: 1007-16.
[49]
Fard A, Esmaelzadeh M, Larijani B. Assessment and treatment of diabetic foot ulcer. Int J Clin Pract 2007; 61(11): 1931-8.
[50]
Aranda S. Designing nursing interventions. Collegian 2008; 15(1): 19-25.
[51]
Frich L. Nursing interventions for patients with chronic conditions. J Adv Nurs 2003; 44(2): 137-53.
[52]
Schumann H, Calow T, Weckesser S, Muller M, Hoffmann G. Water-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study. Br J Dermatol 2011; 165: 541-51.
[53]
Fernandez R, Griffiths R. Water for wound cleansing. Cochrane Database Syst Rev 2012; 15(2) CD003861
[54]
Bellingeri A, Falciani F, Traspedini P, et al. Effect of a wound cleansing solution on wound bed preparation and inflammation in chronic wounds: a single-blind RCT. J Wound Care 2016; 25(3): 160-8.
[55]
Tao Q, Ren J, Ji Z, Wang B, Zheng Y, Li J. Continuous topical irrigation for severely infected wound healing. J Surg Res 2015; 198(2): 535-40.
[56]
Min Y, Hatice H, Alpdogan K, et al. A pilot study evaluating non‐contact low‐frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers. Int Wound J 2014; 11(6): 586-93.
[57]
Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2010; 1 CD003556
[58]
Sarabahi S. Recent advances in topical wound care. Indian J Plast Surg 2012; 45(2): 379-87.
[59]
Kuo Y-S, Chien H-F, Lu W. Plectranthus amboinicus and Centella asiatica cream for the treatment of diabetic foot ulcers. Evid Based Complement Alternat Med 2012; 2012: 9.
[60]
Vaseenon T, Thitiboonsuwan S, Cheewawattanachai C, Pimchoo P, Phanphaisarn A. Off-loading total contact cast in combination with hydrogel and foam dressing for management of diabetic plantar ulcer of the foot. J Med Assoc Thai 2014; 97(12): 1319-24.
[61]
Chirwa Z, Bhengu T, Litiane K. The cost effectiveness of using calcium alginate silver matrix in the treatment of wounds. EWMA J 2010; 2(257): 299.
[62]
Dumville JC, Deshpande S, O’Meara S, Speak K. Foam dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev 2011; 9CD009111
[63]
Huang G, Sun T, Zhang L, et al. Combined application of alginate dressing and human granulocyte-macrophage colony stimulating factor promotes healing in refractory chronic skin ulcers. Exp Ther Med 2014; 7: 1772-6.
[64]
Vassallo I, Formosa C. Comparing calcium alginate dressings to vacuum-assisted closure: a clinical trial. Wounds 2015; 27(7): 180-90.
[65]
Dumville JC, O’Meara S, Deshpande S, Speak K. Alginate dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev 2012; 2CD009110
[66]
O’Meara S, Martyn-St James M, Adderley UJ. Alginate dressings for venous leg ulcers. Cochrane Database Syst Rev 2015; 8 CD010182
[67]
Fleck CA, Simman R. Modern collagen wound dressings: function and purpose. J Am Coll Clin Wound Spec 2010; 2(3): 50-4.
[68]
Andrews K, Houdek M, Kiemele L. Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine. Prosthet Orthot Int 2015; 39(1): 29-39.
[69]
Mir G. Diabetic foot ulcer healing with a silver dressing combined with soft silicone technology. Wounds Int 2013; 4(3): 15-8.
[70]
Tsang K-K, Kwong EW-Y, To TS-S, Chung JW-Y, Wong TK-S. A pilot randomized, controlled study of nanocrystalline silver, manuka honey, and conventional dressing in healing diabetic foot ulcer. Evid.-Based Complementary Altern Med 2017; pp. 1-15.
[71]
Matsumoto Y, Kuroyanagi Y. Development of a wound dressing composed of hyaluronic acid sponge containing arginine and epidermal growth factor. J Biomater Sci Polym Ed 2010; 21(6-7): 715-26.
[72]
Moore AL, Marshall CD, Longaker MT. Minimizing skin scarring through biomaterial design. J Funct Biomater 2017; 8(1): 3.
[73]
Lee M, Han S, Choi W, Chung K, Lee J. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled, single-center study. Wound Rep Reg 2016; 24: 581-8.
[74]
Kavitha KV, Tiwari S, Purandare VB, Khedkar S, Bhosale SS, Unnikrishnan AG. Choice of wound care in diabetic foot ulcer: A practical approach. World J Diabetes 2014; 5(4): 546-56.
[75]
Mohammedi K, Potier L, François M, et al. The evaluation of off-loading using a new removable oRTHOsis in DIABetic foot (ORTHODIAB) randomized controlled trial: study design and rational. J Foot Ankle Res 2016; 9(1): 34.
[76]
Armstrong DG, Nguyen HC, Lavery LA, van Schie CHM, Boulton AJM, Harkless LB. Off-Loading the diabetic foot wound. A randomized clinical trial. Diabetes Care 2001; 24(6): 1019-22.
[77]
Scollan-Koliopoulos M. Theory-guided intervention for preventing diabetes-related amputations in African Americans. J Vasc Nurs 2004; 22(4): 126-33.
[78]
McInnes A, Jeffcoate W, Vileikyte L, et al. Foot care education in patients with diabetes at low risk of complications: a consensus statement. Diabet Med 2011; 28(2): 162-7.
[79]
Muhammad-Lutfi A, Zaraihah M, Anuar-Ramdhan I. Knowledge and practice of diabetic foot care in an in-patient setting at a tertiary medical center. Malays Orthop J 2014; 8(3): 22-6.
[80]
Nemcová J, Hlinková E. The efficacy of diabetic foot care education. J Clin Nurs 2014; 23(5-6): 877-82.
[81]
Ren M, Yang C, Lin DZ, Xiao HS, Mai LF, Guo YC, et al. Effect of intensive nursing education on the prevention of diabetic foot ulceration among patients with high-risk diabetic foot: a follow-up analysis. Diabetes Technol Ther 2014; 16(9): 576-81.
[82]
Holmes C, Wrobel JS, MacEachern MP, Boles BR. Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review. Diabetes Metab Syndr Obes 2013; 6: 17-29.
[83]
Mat Saad AZ, Khoo TL, Halim AS. Wound bed preparation for chronic diabetic foot ulcers. ISRN Endocrinol 2013; 2013608313
[84]
Mulder G, Tenenhaus M, D’Souza G. Reduction of diabetic foot ulcer healing times through use of advanced treatment modalities. Int J Low Extrem Wounds 2014; 13(4): 335-46.
[85]
Vyas KS, Vasconez HC. Wound healing: biologics, skin substitutes, biomembranes and scaffolds. Health Care 2014; 2(3): 356-400.
[86]
You H, Han S, Lee J, Chang H. Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes--a pilot study. Wound Repair Regen 2012; 20(4): 491-9.
[87]
Ma C, Hernandez M, Kirkpatrick V, Liang L, Nouvong A, Gordon I. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial. Wounds 2015; 27(4): 83-91.
[88]
Suresh DH, Suryanarayan S, Sarvajnamurthy S, Puvvadi S. Treatment of a non-healing diabetic foot ulcer with platelet-rich plasma. J Cutan Aesthet Surg 2014; 7(4): 229-31.
[89]
Liu S, He C-Z, Cai Y-T, et al. Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: systematic review and meta-analysis. Ther Clin Risk Manag 2017; 13: 533-44.
[90]
Nain PS, Uppal SK, Garg R, Bajaj K, Garg S. role of negative pressure wound therapy in healing of diabetic foot ulcers. J Surg Tech Case Rep 2011; 3(1): 17-22.
[91]
Kwan R, Wong W, Yip S, Chan K, Zheng Y, Cheing G. Pulsed electromagnetic field therapy promotes healing and microcirculation of chronic diabetic foot ulcers: a pilot study. Adv Skin Wound Care 2015; 28(5): 212-9.
[92]
Löndahl M. Hyperbaric oxygen therapy as treatment of diabetic foot ulcers. Diabetes Metab Res Rev 2012; 28: 78-84.
[93]
Yu J, Lu S, McLaren A-M, Perry JA, Cross KM. Topical oxygen therapy results in complete wound healing in diabetic foot ulcers. Wound Repair Regen 2016; 24(6): 1066-72.
[94]
Wainstein J, Feldbrin Z, Boaz M, Harman-Boehm I. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers. Diabetes Technol Ther 2011; 13(12): 1255-60.
[95]
Dehghan M, Dehghan D, Sheikhrabori A, Sadeghi M, Jalalian M. Quality improvement in clinical documentation: does clinical governance work? J Multidiscip Healthc 2013; 6: 441-50.
[96]
Christman AL, Selvin E, Margolis DJ, Lazarus GS, Garza LA. Hemoglobin A1c is a predictor of healing rate in diabetic wounds. J Invest Dermatol 2011; 131(10): 2121-7.
[97]
Miyajima S, Shirai A, Yamamoto S, Okada N, Matsushita T. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract 2006; 71: 272-9.
[98]
Viswanathan V, Kesavan R, Kavitha KV, Kumpatla S. A pilot study on the effects of a polyherbal formulation cream on diabetic foot ulcers. Indian J Med Res 2011; 134(2): 168-73.
[99]
Nasiri M, Fayazi S, Jahani S, Yazdanpanah L, Haghighizadeh MH. The effect of topical olive oil on the healing of foot ulcer in patients with type 2 diabetes: a double-blind randomized clinical trial study in Iran. J Diabetes Metab Disord 2015; 14: 38.
[100]
Hunt SD, Elg F. Clinical effectiveness of hemoglobin spray (Granulox(®)) as adjunctive therapy in the treatment of chronic diabetic foot ulcers. Diabet Foot Ankle 2016; 7: 33101.
[101]
Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg 2017; 38(Suppl. C): 206-11.
[102]
Ikura K, Hanai K, Shinjyo T, Uchigata Y. HDL cholesterol as a predictor for the incidence of lower extremity amputation and wound-related death in patients with diabetic foot ulcers. Atherosclerosis 2015; 239(2): 465-9.
[103]
Massara M, Caridi GD, Serra R, et al. The role of procalcitonin as a marker of diabetic foot ulcer infection. Int Wound J 2017; 14(1): 31-4.
[104]
Park JH, Suh DH, Kim HJ, Lee YI, Kwak IH, Choi GW. Role of procalcitonin in infected diabetic foot ulcer. Diabetes Res Clin Pract 2017; 128(Suppl. C): 51-7.
[105]
Umapathy D, Dornadula S, Rajagopalan A, et al. Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers. J Vasc Surg 2018; 67(4): 1283-91.
[106]
Reiner MM, Khoury WE, Canales MB, et al. Procalcitonin as a biomarker for predicting amputation level in lower extremity infections. J Foot Ankle Surg 2017; 56(3): 484-91.
[107]
McArdle C, Lagan K, Spence S, McDowell D. Diabetic foot ulcer wound fluid: the effects of pH on DFU bacteria and infection. J Foot Ankle Res 2014; 8(Suppl. 1): A8.
[108]
Gethin G, Cowman S, Conroy R. The impact of Manuka honey dressings on the surface pH of chronic wounds. Int Wound J 2008; 5(2): 185-94.
[109]
Shetty R, Sreekar H, Lamba S, Gupta AK. A novel and accurate technique of photographic wound measurementIndian J. Plast Surg 2012; 45(2): 425-9.
[110]
Mohajeri G, Safaee M, Sanei MH. Effects of topical Kiwifruit on healing of neuropathic diabetic foot ulcer. J Res Med Sci 2014; 19(6): 520-4.